Internal and Emergency Medicine

, Volume 13, Issue 7, pp 1131–1132 | Cite as

Not all kidney disease in patients with diabetes is diabetic nephropathy

  • Abhilash KoratalaEmail author
  • Gajapathiraju Chamarthi
  • Edlira Maska
  • William L. Clapp
A 63-year-old man with a history of diabetes mellitus type 2 diagnosed ~ 30 years ago associated with non-proliferative diabetic retinopathy, hypertension, chronic kidney disease stage 3 and congestive heart failure (CHF) was seen in nephrology clinic for evaluation of worsening kidney function. He did not have any symptoms except for fatigue, and denied taking any new medications or exposure to intravenous contrast in the recent past. His diabetes was well-controlled with a hemoglobin A1c of 6.3%, and blood pressure in the clinic was 124/75 mmHg. Laboratory data were significant for a serum creatinine of 5.1 mg/dL (~ 2.7 2 months prior and 1.4 a year ago) with an estimated glomerular filtration rate (eGFR) of 11 ml/min and urine protein–creatinine ratio of 3 g/g (no baseline available). Urinalysis was unremarkable except for 3+ proteinuria on dipstick. There was no peripheral eosinophilia. Renal sonogram was negative for obstructive uropathy, and demonstrated approximately 12.5-cm...




Compliance with ethical standards

Conflict of interest


Statement of human and animal rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

Informed consent was obtained from the patient for their anonymized data to be published.


  1. 1.
    Bergner R, Lenz T, Henrich DM, Hoffmann M et al (2006) Proteinuria in diabetic patients—is it always diabetic nephropathy? Kidney Blood Press Res 29(1):48–53CrossRefPubMedGoogle Scholar
  2. 2.
    Ghani AA, Al Waheeb S, Al Sahow A, Hussain N (2009) Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions. Ann Saudi Med 29(6):450–453CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Palladini G, Russo P, Bosoni T, Verga L et al (2009) Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem 55(3):499–504CrossRefPubMedGoogle Scholar
  4. 4.
    Sanchorawala V (2006) Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol 1(6):1331–1341CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2018

Authors and Affiliations

  1. 1.Department of MedicineUniversity of FloridaGainesvilleUSA
  2. 2.Department of Pathology, Immunology and Laboratory MedicineUniversity of FloridaGainesvilleUSA
  3. 3.Division of Nephrology, Hypertension and Renal TransplantationUniversity of FloridaGainesvilleUSA

Personalised recommendations